SENSEX 81451.01 (-0.22)
Nifty 50 24750.7 (-0.33)
Nifty Bank 55749.7 (0.37)
Nifty IT 37321.75 (-1.15)
Nifty Midcap 100 57420 (-0.06)
Nifty Next 50 66761.3 (-0.50)
Nifty Pharma 21442.05 (-0.68)
Nifty Smallcap 100 17883.3 (-0.03)
NIKKEI 225 37965.1 (-1.22)
HANG SENG 23289.77 (-1.20)
S&P 5925.5 (-0.16)
BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |
Hot Pursuit 30-May-2025 (09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Corporate News 30-May-2025 (09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Corporate News 20-May-2025 (12:49) Board of Marksans Pharma recommends final dividend
Results 20-May-2025 (07:46) Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Corporate News 19-May-2025 (13:29) Relonchem receives marketing authorization for Sennosides 7.5 mg tablets
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others